TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ALMS

Alumis Inc

Healthcare · Biotechnology · —

7.90$ +1.7% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

Alumis Inc (ALMS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1.7 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ALMS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
0.0 0.0 0.0 0.0 0.0 3.0 17 2.7 2.1 1.9 1.7 1.7 7.4
0.3 0.7 0.8 0.8 0.8 0.8 0.9 0.9 0.9
-0.3 -0.7 -0.8 -0.8 -0.8 -0.8 17 2.7 2.1 1.9 0.9 1.7 6.5
38 35 41 49 88 86 97 109 98 83 81 85 347
6.0 5.5 5.6 7.6 11 11 22 21 20 16 19 23 77
44 40 47 56 98 98 119 143 117 98 99 151 466
-44 -40 -48 -56 -98 -99 -102 -141 -115 -96 -98 -149 -459
-43 -39 -50 -57 -93 -95 -99 51 -111 -93 -93 -144 -441
-8.6 -1.8
-43 -39 -50 -57 -93 -95 -99 59 -111 -93 -93 -142 -439
-43 -39 -49 -56 -92 -94 -98 -120 -110 -92 -92 -149 -443

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?